Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?

by John G. Gribben, Elisabeth de Vries, Nathan I. Cherny, Pieter Sonneveld
Published 2020-04-01

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells

by Gerke Ariaans, Mathilde Jalving, Emma Geertruida Elisabeth de Vries, Steven de Jong
Published 2017-03-01

BMI and lifetime changes in BMI and cancer mortality risk.

by Niloofar Taghizadeh, H Marike Boezen, Jan P Schouten, Carolien P Schröder, E G Elisabeth de Vries, Judith M Vonk
Published 2015-01-01

European Academy of Cancer Sciences – position paper

by Hans‐Olov Adami, Anton Berns, Julio E. Celis, Elisabeth deVries, Alexander Eggermont, Adrian Harris, Harald zur Hausen, Pier Giuseppe Pelicci, Ulrik Ringborg
Published 2018-11-01